DrugPatentWatch Database Preview
Litigation Details for Novo Nordisk Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)
» See Plans and Pricing
Novo Nordisk Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)
| Docket | Start Trial | Date Filed | 2017-03-03 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | |
| Jury Demand | None | Referred To | |
| Patents | 6,235,004; 6,268,343; 8,114,833; 8,846,618; 9,265,893; RE41,956 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Novo Nordisk Inc. v. Teva Pharmaceuticals USA, Inc.
The small molecule drugs covered by the patents cited in this case are Start Trial , Start Trial , and Start Trial .
Biologic Drugs cited in Novo Nordisk Inc. v. Teva Pharmaceuticals USA, Inc.
The biologic drugs covered by the patents cited in this case are Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , and Start Trial .
Details for Novo Nordisk Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-06-26 | 61 | Report and Recommendations | ., 1:24-26 ("U.S. Pat. No. 6,235,004 [("the '004 patent")] discloses an injection device….S. Patent Nos. 6,268,343 ("the '343 patent"); 8,114,833 ("the '833 patent"…(EP '581 patent at 17), as do similar figures in the '004 patent, '004 patent, figs. 15-16…the '004 patent. '893 patent, 1:29-34 (citing Figs. 15-16 of the '004 patent) ("[T]he….S. Patent Nos. 8,114,833 ("the '833 patent"); 9,265,893 ("the '893 patent" | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
